ADHD affects an estimated 3% to 5% of children and adults in the U.S. Dr. Richard Sogn shares information and advice about attention deficit hyperactivity disorder, including its causes, diagnosis, and promising ADHD treatments
Visit ADHD Medications and Treatments
Strattera Approved for Maintenance Treatment of ADHD in Children and Adolescents
Posted on June 11, 2008
The FDA has approved Strattera for maintenance treatment of ADHD in children and adolescents. This is important as ADHD is often a chronic problem, with symptoms often persisting into adulthood that require long-term treatment. An 18-month relapse prevention study of approximately 600 children and adolescents aged 6 to 15 years old was conducted. Of those who responded to initial, acute treatment with Strattera (approximately 69%), only 2.5% relapsed with continued treatment. The most common side effects in this study were headache and the common cold. In summary, Strattera is effective for...
Original article link
Subscribe to ADHD Medications and Treatments